Diagnosis of HIV: Challenges and strategies for HIV prevention and detection among pregnant women and their infants

Clinics in Perinatology

Volumn 37, Issue 4, 2010, Pages 751-763

  Donovan, Margery ^a   Palumbo, Paul ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Antiretroviral prophylaxis; HIV diagnostics; Human immunodeficiency virus; Perinatal HIV; Pregnancy

Indexed keywords

ZIDOVUDINE;

ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFORMED CONSENT; NUCLEIC ACID AMPLIFICATION; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRENATAL CARE; PRENATAL SCREENING; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; UNPLANNED PREGNANCY; VERTICAL TRANSMISSION; VIRUS CULTURE; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; CONTRACEPTION; FAMILY; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MANDATORY TESTING; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL CARE; PRIMARY PREVENTION;

EID: 78349261469     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.08.014     Document Type: Review

References (47)

1. Barre-Sinoussi F., Chermann J.C., Rey F., et al. Isolation of a T-lymphocyte retrovirus from a patient at risk for AIDS. Science 1983, 220(4599):868-871.
2. Gallo R.C., Salahuddin S.Z., Popovic M., et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224(4648):500-503.
3. Oleske J., Minnefor A., Cooper R., et al. Immune deficiency syndrome in children. JAMA 1983, 249:2345-2349.
4. Rubinstein A., Sicklick M., Gupta A., et al. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug addicted mothers. JAMA 1983, 249:2350-2356.
5. Scott G.B., Buck B.E., Letermann J.G., et al. Acquired immunodeficiency syndrome in infants. N Engl J Med 1984, 310:76-81.
6. Chou R., Smits A.K., Huffman L.H., et al. US Preventive Services Task Force. Prenatal screening for HIV: a review of the evidence for the U.S. preventive services task force. Ann Intern Med 2005, 143(1):38-54.
7. McKenna M.T., Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol 2007, 197(Suppl 3):S10-S16.
8. Data for perinatal HIV prevention. Consultation on prevention of mother-to-child HIV transmission in the United States. April 1-3, 2008.
9. Kalyanaraman V.S., Cabradilla C.D., Getchell J.P., et al. Antibody to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science 1984, 225(4659):321-323.
10. Sarngadharan M.G., Popovic M., Bruch L., et al. Antibodies reactive with human T-lymphotropic retrovirus (HTLV-III) in the serum of patients with AIDS. Science 1984, 224(4648):506-508.
11. Mullis K.B., Faloona F.A., Scharf S.J., et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol 1986, 51:263-267.
12. Ou C.Y., Kwok S., Mitchell S.W., et al. DNA amplification for direct detection of HIV-1 in DNA or peripheral blood mononuclear cells. Science 1988, 239(4836):295-297.
13. Rogers M., Ou C.Y., Rayfield M., et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City collaborative study of maternal HIV transmission and Montefiore Medical Center HIV perinatal transmission study group. N Engl J Med 1989, 320:1949-1954.
14. CDC Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989, 38:1-7.
15. CDC Serologic testing for HIV-1 antibody-United States, 1988 and 1989. MMWR Morb Mortal Wkly Rep 1990, 39(22):380-383.
16. Branson B.M., Handsfield H.H., Lampe M.A., et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006, 55(RR-14):1-17.
17. Mahajan A.P., Stemple L., Shapiro M.F., et al. Consistency of state statues with the centers for disease control and prevention HIV testing recommendations for health care settings. Ann Intern Med 2009, 150(4):263-269.
18. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for the use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. May 24, 2010. p. 1-117. Available at: Accessed August 25, 2010. http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf.
19. Bryant A.S., Leighty R.M., Shen X., et al. Predictors of repeat pregnancy among HIV-1 infected women. J Acquir Immune Defic Syndr 2007, 44(1):87-92.
20. Koenig L.J., Espinoza L., Hodge K., et al. Young, seropositive, and pregnant: epidemiologic and psychosocial perspectives on pregnant adolescents with human immunodeficiency virus infection. Am J Obstet Gynecol 2007, 197(3):S123-S131.
21. Blood E., Beckwith C., Bazerman L., et al. Pregnancy among HIV-infected refugees in Rhode Island. AIDS Care 2009, 21(2):207-211.
22. Abatemarco D.J., Catov J.M., Cross H., et al. Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey. J Health Care Poor Underserved 2008, 19(3):814-828.
23. Sarnquist C.C., Cunningham S.D., Sullivan B., et al. The effectiveness of state and national policy on the implementation of perinatal HIV prevention interventions. Am J Public Health 2007, 97(6):1041-1046.
24. Potter J.E., Pereyra M., Lampe M., et al. Factors associated with prenatal care use among peripartum women in the mother-infant rapid intervention at delivery study. J Obstet Gynecol Neonatal Nurs 2009, 38(5):534-543.
25. CDC Achievements in public health: reduction in perinatal transmission of HIV infection-United States, 1985-2005. Morb Mortal Wkly Rep 2006, 55(21):592-597.
26. Cohen M.H., Olszewski Y., Webber M.P., et al. Women identified with HIV at labor and delivery: testing, disclosing and linking to care challenges. Matern Child Health J 2008, 12(5):568-576.
27. Peters V.B., Liu K.L., Robinson L.G., et al. Trends in perinatal HIV prevention in New York City, 1994-2003. Am J Public Health 2008, 98(10):1857-1864.
28. CDC Enhanced perinatal surveillance-United States, 1999-2001 2004, U.S. Department of Health and Human Services, Atlanta (GA), Report nr 4.
29. Fielder O., Altice F.L. Attitudes toward and beliefs about prenatal HIV testing policies and mandatory HIV testing of newborns among drug users. AIDS Public Policy J 2005, 20(3-4):74-91.
30. AAP Committee on Pediatric AIDS HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008, 122(5):1127-1134.
31. Pai N.P., Tulsky J.P., Cohan D., et al. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis. Trop Med Int Health 2007, 12:162-173.
32. Rahangdale L., Sarnquist C., Feakins C., et al. Rapid HIV testing on labor and delivery. J Acquir Immune Defic Syndr 2007, 46:376-378.
33. Association of Public Health Laboratories and CDC. HIV testing algorithms-a status report. Silver Spring (MD): Association of Public Health Laboratories; April 2009.
34. ACOG Committee on Obstetric Practice ACOG committee opinion no. 418: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol 2008, 112(3):739-742.
35. HIV testing for mothers and newborns [Internet]; February 2008 Available at:, Accessed July 2010. http://statehealthfacts.org.
36. Gray A.D., Carlson R., Morgan M.A., et al. Obstetrician gynecologists' knowledge and practice regarding human immunodeficiency virus screening. Obstet Gynecol 2007, 110(5):1019-1026.
37. Olges J.R., Murphy B.S., Caldwell G.G., et al. Testing practices and knowledge of HIV among prenatal care providers in a low seroprevalence state. AIDS Patient Care STDS 2007, 21(3):187-194.
38. Webber M.P., Demas P., Blaney N., et al. Correlates of prenatal HIV testing in women with undocumented status at delivery. Matern Child Health J 2008, 12(4):427-434.
39. Podhurst L.S., Storm D.S., Dolgonos S. Women's opinions about routine HIV testing during pregnancy: implication for the opt-out approach. AIDS Patient Care STDS 2009, 23(5):331-337.
40. Criniti S.M., Aaron E., Levine A.B. Using the rapid HIV test to rescreen women in the third trimester of pregnancy. J Midwifery Womens Health 2009, 54(6):492-496.
41. Gaur S., Whitley-Williams P., Flash C., et al. Disparity in hospital utilization of rapid HIV-1 testing for women in labor with undocumented HIV status. Matern Child Health J 2010, 14(2):268-273.
42. Peters V., Liu K.L., Dominguez K., et al. Missed opportunities for perinatal HIV prevention among HIV exposed infants born 1996-2000, pediatric spectrum of disease cohort. Pediatrics 2003, 111(5 Part 2):1186-1191.
43. Havens P.L., Mofenson L.M. AAP Committee on Pediatric AIDS. Evaluation and management of the infant exposed to HIV-1 in the United States. Pediatrics 2009, 123:175-187.
44. Bryson Y.J., Luzuriaga K., Sullivan J.L., et al. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992, 327:1246-1247.
45. Read J.S., Brogly S., Basar M., et al. HIV diagnostic testing of infants at clinical sites in North America: 2002-2006. Pediatr Infect Dis J 2009, 28:614-618.
46. Dunn D.T., Brandt C.D., Krivine A., et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995, 9:F7-11.
47. Shannon M., Lee K.A. HIV-infected mothers' perceptions of uncertainty, stress, depression and social support during HIV viral testing of their infants. Arch Womens Ment Health 2008, 11(4):259-267.